Down‐regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen‐2) 27 rats
Open Access
- 1 May 1997
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 121 (1) , 134-140
- https://doi.org/10.1038/sj.bjp.0701088
Abstract
Transgenic(TG) (mRen‐2) rats overexpressing the mouse renin gene develop fulminant hypertension and cardiac hypertrophy. Since the activation of AT1 receptor by angiotensin II is involved in blood pressure regulation, cardiac performance and myocardial growth, we investigated the biological effects of angiotensin II and the regulation of the AT1 receptor in the heart and aorta of TGR (mRen‐2)27 rats in comparison to control animals. Contraction studies on isolated cardiac muscle strips reveal that angiotensin II exerts no positive inotropic effect on the left ventricular myocardium of both, transgenic and control rats. In contrast, angiotensin II leads via AT1 receptor activation in the left atrium of control rats to a significant contraction (130±5% of basal contraction) which is not detectable in left atrium preparations of the transgenic animals. Furthermore, AT1 receptor activation causes a profound contraction of aortic rings isolated from control rats amounting to 1.39±0.2 mN mg−1 wet weight, whereas aortic rings from TGR (mRen‐2)27 rats contract only minimally upon angiotensin II stimulation (0.2±0.02 mN mg−1 wet weight). These altered physiological responses of angiotensin II in the transgenic rats are in part due to a marked down‐regulation of the AT1 receptor in atrial, ventricular and aortic tissue of these transgenic animals in comparison to control Sprague‐Dawley rats, as shown by radioligand binding assays and quantitative polymerase chain reaction (PCR) experiments. The AT1 receptor density Bmax in the left atrium was 1.3±0.08 fmol mg−1 protein in control rats (KD 1.1±0.18 nmol l−1) and 0.94±0.15 fmol mg−1 protein (KD 2.1±0.3 nmol l−1. In the aorta Bmax values were 15.1±0.5 fmol mg−1 protein (KD 1.9±0.27 nmol l−1) for control rats and 11.3±0.76 fmol mg−1 protein (KD 1.9±0.27 nmol l−1) for the TGR(mRen‐2)27 rats AT1 receptor mRNA was reduced in the transgenic animals to 46±3% in the left atrium, 50±11% in the left ventricle and 40±3% in the aorta, respectively. Together, the AT1 receptor is down‐regulated in TGR (mRen‐2)27 rats in comparison to wildtype Sprague Dawley rats leading to a profoundly decreased response of cardiac and aortic tissue upon stimulation with angiotensin II. British Journal of Pharmacology (1997) 121, 134–140; doi:10.1038/sj.bjp.0701088Keywords
This publication has 33 references indexed in Scilit:
- Contractile properties of left ventricular myocytes isolated from spontaneously hypertensive ratsJournal Of Hypertension, 1995
- Angiotensin II Induces Cardiac Phenotypic Modulation and Remodeling In Vivo in RatsHypertension, 1995
- Functional vascular renin-angiotensin system in hypertensive transgenic rats for the mouse renin gene Ren-2General Pharmacology: The Vascular System, 1994
- Increased vascular angiotensin formation in female rats harboring the mouse Ren-2 gene.Hypertension, 1992
- Transgenic rats: new animal models in hypertension research. Invited lecture.Hypertension, 1991
- Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 geneNature, 1990
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.Circulation, 1981
- Regulation by angiotensin II of its receptors in resistance blood vesselsNature, 1980
- Wall stress and patterns of hypertrophy in the human left ventricle.Journal of Clinical Investigation, 1975